Clinical Trial Update: Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating PPAR-gamma activation in patients undergoing peritoneal dialysis for end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• PPAR-gamma activation (agent unspecified in snippet)

Snippet

Sponsor: The University of Hong Kong | Conditions: End-stage Renal Disease | Phase 4 | Status: COMPLETED